Scarica l'app Stockscreener
92.83
1.86%
-1.925
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$94.75
Aprire:
$94.7
Volume 24 ore:
1.70M
Relative Volume:
0.88
Capitalizzazione di mercato:
$18.40B
Reddito:
$7.83B
Utile/perdita netta:
$825.20M
Rapporto P/E:
22.60
EPS:
4.1067
Flusso di cassa netto:
$1.05B
1 W Prestazione:
+3.41%
1M Prestazione:
-1.37%
6M Prestazione:
+0.45%
1 anno Prestazione:
-9.84%
Intervallo 1D:
$91.91
$95.25
Intervallo di 1 settimana:
$89.50
$95.31
Portata 52W:
$85.33
$114.44
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Confronta ZBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
92.86 | 18.78B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
127.09 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.88 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.81 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet inks a partnership with PatientIQ - MassDevice
Sivik Global Healthcare LLC Buys New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Absher Wealth Management LLC Invests $2.34 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet stock: Is ZBH underperforming the health care sector? - MSN
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
Raymond James Downgrades Zimmer Biomet to Market Perform From Outperform - marketscreener.com
Evercore ISI Group Upgrades Zimmer Biomet Holdings (ZBH) Rating - GuruFocus
Who Owns Zimmer Biomet? Top Shareholders and Recent Insider Trades - TIKR.com
What analysts say about Zimmer Biomet Holdings Inc stockSmall Cap Stock Opportunities & High Profit Trading Plans - earlytimes.in
Pacer Advisors Inc. Cuts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Calamos Advisors LLC Has $4.66 Million Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet lawsuit against Deloitte Consulting continues to move through New York court - The Journal Gazette
Cervical Total Disc Replacement Device Market 2025 Forecast: - openPR.com
Earnings Update: Will Zimmer Biomet Holdings Inc stock outperform value stocksJuly 2025 Momentum & Daily Technical Stock Forecast Reports - moha.gov.vn
Zimmer Biomet Holdings, Inc.: - marketscreener.com
Boston Trust Walden Corp Has $65.02 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Collagen Meniscus Implant Market Forecast: Unveiling - openPR.com
Kempner Capital Management Inc. Sells 27,095 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Ex-Dividend Reminder: John Wiley & Sons, Xcel Energy and Zimmer Biomet Holdings - Nasdaq
Zimmer Biomet Holdings, Inc. $ZBH is QSM Asset Management Ltd's Largest Position - MarketBeat
Voya Investment Management LLC Has $5.36 Million Stock Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zacks Research Predicts Weaker Earnings for Zimmer Biomet - MarketBeat
Is Zimmer Biomet Holdings Inc. stock a buy in volatile marketsGlobal Market Influence & Capital Allocation Recommendations - Bollywood Helpline
Zimmer Biomet: Execution Remains The Sticking Point (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
EBITDA per share of Zimmer Biomet Holdings, Inc. – FWB:ZIM - TradingView — Track All Markets
Wedge Capital Management L L P NC Sells 17,263 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet to Present at the 44th Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
Douglas Lane & Associates LLC Purchases 29,011 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Rating of "Hold" by Brokerages - MarketBeat
Benson Investment Management Company Inc. Acquires New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Have Endured a 36% Loss From Investing in the Stock Five Years Ago - 富途牛牛
Is Zimmer Biomet Holdings Inc. stock overvalued by current metricsQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Why Zimmer Biomet Holdings Inc. (ZIM) stock is a strong analyst pickMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Yahoo Finance
How Investors Are Reacting To Zimmer Biomet (ZBH) Dividend Move And OneStep Digital Recovery Partnership - simplywall.st
Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Will Zimmer Biomet Holdings Inc. stock benefit from sector rotationMarket Growth Report & Consistent Growth Stock Picks - Улправда
Bactiguard Announces Updated Trauma License Agreement with Zimmer Biomet - marketscreener.com
How Zimmer Biomet Holdings Inc. stock reacts to job market data2025 Major Catalysts & Reliable Price Breakout Alerts - DonanımHaber
How Zimmer Biomet Holdings Inc. (ZIM) stock valuation compares with sectorJuly 2025 Update & Expert-Curated Trade Recommendations - DonanımHaber
Bactiguard Updates Licensing Agreement with Zimmer Biomet - marketscreener.com
Bactiguard announces updated trauma license agreement with Zimmer Biomet - marketscreener.com
Will Zimmer Biomet Holdings Inc. stock outperform value stocksPortfolio Performance Report & Weekly Return Optimization Plans - DonanımHaber
What risks investors should watch in Zimmer Biomet Holdings Inc. stock - DonanımHaber
How Zimmer Biomet Holdings Inc. stock performs during Fed tightening cyclesQuarterly Trade Report & Community Consensus Trade Signals - DonanımHaber
What momentum indicators show for Zimmer Biomet Holdings Inc. stockJuly 2025 Closing Moves & Advanced Technical Signal Analysis - DonanımHaber
Why retail investors pile into Zimmer Biomet Holdings Inc. stockJuly 2025 Levels & Daily Entry Point Trade Alerts - DonanımHaber
Fund Flows: Why Zimmer Biomet Holdings Inc. (ZIM) stock is a strong analyst pick2025 EndofYear Setup & Fast Exit and Entry Trade Guides - Улправда
How Zimmer Biomet Holdings Inc. stock valuations compare to rivalsQuarterly Market Review & Fast Entry High Yield Stock Tips - DonanımHaber
Why Zimmer Biomet Holdings Inc. stock appeals to dividend seekers2025 Risk Factors & Real-Time Volume Surge Alerts - Улправда
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):